Mogelijk gemaakt door Google TranslateTranslate
Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Latest Press Releases
View all
TimeHeadline
10m agoNayax to Report 2026 Q1 Earnings on May 12, 2026
38m agoCC Capital and OneIM Complete Acquisition of Insignia Financial Limited, Australia's Leading Diversified Wealth Management Group
1h agoCanadian Gold Resources Strengthens Board with Capital Markets Veteran Kenneth Chernin
1h agoWaraba Gold Signs Binding Agreement to Establish Joint Venture Relating to Tengrela South Exploration Permit Application in Cote d'Ivoire
1h agoSierra Madre Announces Shareholder Approval of Acquisition of Del Toro Silver Mine
Gb Sciences Inc logo

Gb Sciences Inc

About

Gb Sciences Inc (PINK:GBLX) — investor relations, events, news, and company updates on 6ix.

Latest News

Dec 22 2022
Gb Sciences Identifies Novel Cannabis-Inspired Mixtures as Anti-Inflammatory Therapies Based on Proprietary AI-Enabled Drug Discovery Platform
Dec 12 2022
Gb Sciences Addresses Growing Need for Anxiety and Depression Medications With Non-Psychedelic, Kava-Based Formulations
Nov 1 2022
Gb Sciences Co-Publishes Study Demonstrating Anti-Inflammatory Properties of Cannabis Ingredients
Oct 27 2022
TODAY: Gb Sciences' President Demonstrates Benefits of AI-Enabled Drug Discovery Engine for Novel Plant-Inspired Pharmaceuticals at 10th Annual Drug Discovery Strategic Summit
Oct 24 2022
Gb Sciences' Plant-based Formulations Designed to Treat Anxiety Achieve Statistical Significance in Animal Study

Financials

Revenue
$97.23 K
Market Cap
$122.12 K
EPS
0.00

Community Chat

Ask AI

6ix6ixAIEvents